<DOC>
	<DOC>NCT01616511</DOC>
	<brief_summary>The objective of the study is to demonstrate the long-term safety and performance of the ATI Neurostimulation System when used for stimulation of the sphenopalatine ganglion (SPG) in cluster headache subjects.</brief_summary>
	<brief_title>Pathway CH-1 Long-Term Follow-Up</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>Subject has been implanted with an ATI Neurostimulator as a part of the Pathway CH1 trial. Subject has completed the Pathway CH1 Open Label Final office visit and remains implanted with an ATI Neurostimulator. Subject has the ability to read, comprehend and to reliably record information as required by the Protocol. Subject is able to provide written informed consent prior to participation in the study. Subject has or requires a pacemaker/defibrillator or other implantable device having a sense amplifier that is programmed 'On.' Subject is not suitable for the study for any reason in the judgment of the Investigator.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>